Neuralink, co-founded by Elon Musk and a team of experts in 2016, is developing advanced brain-computer interfaces (BCIs) to connect the human brain with artificial intelligence. The company's wireless, implantable BCI uses flexible electrode threads to record and stimulate neural activity. In 2023, Neuralink received FDA approval to begin its first human clinical trial.
The Neuralink founding team includes Elon Musk (CEO), Max Hodak, Vanessa Tolosa, and DJ Seo (VP of Engineering), bringing deep expertise from top institutions like Stanford, MIT, and IBM. Other key leaders include Jared Birchall (CFO/Secretary). To date, Neuralink has raised over $650 million in funding.
Neuralink's mission is to scale its BCI technology to treat neurological disorders affecting millions worldwide. However, the company faces challenges in demonstrating real-world efficacy, ensuring safety, and gaining public acceptance of brain implants. Joining Neuralink means being part of a top-tier team pushing the boundaries of neurotechnology, but employees should be prepared for an intense, fast-paced environment as the company races to bring its first product to market.
2016
Founded
250-500
Employees
Series D
Stage
$3.5B
Latest Valuation
$400-700M
Total Funding
Nov 11 2023
Last Fundraise
Why is the rating
Historical Peer Benchmarks
Oscar Health 2018
$4.5B (2018)
$7.9B (at direct listing) (2021)
Gusto 2019
$3.8B (2019)
$9.63B (2022)
GRAIL 2018
$3.2B (2018)
$9.80B (at acquisition) (2021)
Top Previous Employers
Stanford University
Tesla
Lyft
SpaceX
Investors
Founders Fund
Facebook, SpaceX, Affirm